We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in NKGen Biotech, Inc. Warrants in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $14.1K → $0 (-$14.1K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Rivernorth Capital Management
Florida
-$13.1K
2
MTCM
Mint Tower Capital Management
Netherlands
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
– -$13.1K -652,432 Closed
MTCM
2
Mint Tower Capital Management
Netherlands
– -$1K -40,000 Closed

NKGNW Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2025, worth a combined $0 — down 100% from $14.1K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NKGNW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Rivernorth Capital Management, exiting entirely with an estimated $13.1K sold.

  • 0 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2025, down from 3 in Q1 2025.
  • Funds reported $0 of NKGen Biotech, Inc. Warrants stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2025 and 3 closed out, a net change of -3 holders.
  • The largest NKGen Biotech, Inc. Warrants seller in Q2 2025 was Rivernorth Capital Management, an estimated $13.1K sold.

Based on aggregated 13F filings for Q2 2025.